UAB "Rovifarma" vaistinė Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 19,501,646 |
| 2,437,706 |
| 260,960 |
| 221,012 |
| 27,627 |
| 2.63 |
| 1.13 |
| 719,982 |
| 3,676,492 |
| 1,182,265 |
| 3,209,683 |
| 2024 |
|---|
| 22,927,622 |
| 2,958,403 |
| 210,490 |
| 177,293 |
| 22,877 |
| 2.01 |
| 0.77 |
| 897,275 |
| 4,248,879 |
| 1,108,578 |
| 4,034,933 |
| 2025 |
|---|
| 31,546,115 |
| 3,262,266 |
| 235,605 |
| 199,240 |
| 20,604 |
| 1.93 |
| 0.63 |
| 1,096,515 |
| 4,929,312 |
| 1,041,320 |
| 4,983,022 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 31,546,115 |
| 3,262,266 |
| 235,605 |
| 199,240 |
| 20,604 |
| 1.93 |
| 0.63 |
| 1,096,515 |
| 4,929,312 |
| 1,041,320 |
| 4,983,022 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
31,546,115 €38 % *
Sales per employee (€)
3,262,266 €10 % *
Profit before tax (€)
235,605 €12 % *
Net Profit (€)
199,240 €12 % *
Profit per employee (€)
20,604 €-10 % *
Total profitability (%)
1.93 %-3.98 % *
Net profitability (%)
0.63 %-18.18 % *
Equity (€)
1,096,515 €22 % *
Amounts Payable And Liabilities (€)
4,929,312 €16 % *
Non-current Assets (€)
1,041,320 €-6 % *
CurrentAssets (€)
4,983,022 €24 % *
